by Hiroyuki Morita, and Issei Komuro

Slides:



Advertisements
Similar presentations
1 Chapter 77 - Ischemic Renal Disease Copyright © 2013 Elsevier Inc. All rights reserved.
Advertisements

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.
Bariatric Surgery and Cardiovascular Risk Factors by Paul Poirier, Marc-André Cornier, Theodore Mazzone, Sasha Stiles, Susan Cummings, Samuel Klein, Peter.
The Epidemic of the 20th Century: Coronary Heart Disease
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India by Rohina Joshi, Clara K. Chow,
EMPA-REG OUTCOME: The Endocrinologist's Point of View
by Adolfo Correa, Sophia Greer, and Mario Sims
Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,
by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D
Atrial Fibrillation and Mortality in Heart FailureClinical Perspective
Old Drug, New Tricks by Alan T. Remaley Circulation Research
CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.
by Kiran Musunuru, and Sekar Kathiresan
Prime Time for JNK-Mediated Akt Reactivation in Hypoxia-Reoxygenation
Value-Based Hypothesis Testing for Cardiac Device Clinical Trials
Primitive Macrophages Drive Coronary Development
Circ Cardiovasc Qual Outcomes
by Edward E. Morrisey Circulation Research Volume 109(6):
Site Selection and Performance in Clinical Trials
So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients
Effect of Low Cholesterol on Steroid Hormones and Vitamin E Levels
Behavior and Biology: The Basic Sciences for AHA Action
Plasma Free Fatty Acids and Risk of Heart FailureClinical Perspective
by Thomas Monks, Martin Pitt, Ken Stein, and Martin James
Contribution of Stroke to the Cochrane Stroke Group Trials Register
Effect of Provider Volume on the Accuracy of Hospital Report Cards
by Johan Denollet, Angélique A. Schiffer, and Viola Spek
The “Natural Selection” of Muscle for Cardiac Repair
Mathematical representation of Bayes theorem.
Circ Cardiovasc Qual Outcomes
Potassium Channels and Proliferation of Vascular Smooth Muscle Cells
EMPA-REG OUTCOME: The Endocrinologist's Point of View
The Epidemic of the 20th Century: Coronary Heart Disease
Copyright © 2012, Elsevier Inc. All rights Reserved.
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Classified Advertising
Application of a neuroscience research model to study neuroprotection in children with congenital heart disease  Nobuyuki Ishibashi, MD, Richard A. Jonas,
Epidemiology and Adverse Cardiovascular Disease (CVD) Risk Profile of Polycystic Ovarian Syndrome (PCOS): The Kaiser Permanente Polycystic Ovarian Syndrome.
Dorothea Nitsch, MD, MSc  American Journal of Kidney Diseases 
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Copyright © 2014, 2000, 1992 Elsevier Inc. All rights reserved.
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Use of Diuretics in Heart Failure: A Precarious Balance
Seeing a tree through the forest: Precision medicine tools can enhance donor allocation in heart transplantation  Vishnu Vasanthan, MD, Paul W.M. Fedak,
Copyright © 2012, Elsevier Inc. All rights Reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Section 10.5 The Dot Product
Modeling Functionality with Use Cases
Unit 4 Review Answers.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Trial Quality in Nephrology: How Are We Measuring Up?
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Apparently, size matters…in congenital heart disease and brain injury
The continuing challenge of congenital heart disease in China
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
Copyright © 2012, Elsevier Inc. All rights Reserved.
“The more things change…”: The challenges ahead
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Chapter 77 Cervical Cancer: Burden of Disease
This Month in AJKD American Journal of Kidney Diseases
Jenna Barton, MSN, RN-C, PCCN
Presentation transcript:

by Hiroyuki Morita, and Issei Komuro A Strategy for Genomic Research on Common Cardiovascular Diseases Aiming at the Realization of Precision Medicine by Hiroyuki Morita, and Issei Komuro Circulation Research Volume 119(8):900-903 September 30, 2016 Copyright © American Heart Association, Inc. All rights reserved.

Schematic representation of genomic research on common diseases toward the realization of precision medicine. Schematic representation of genomic research on common diseases toward the realization of precision medicine. Hiroyuki Morita, and Issei Komuro Circ Res. 2016;119:900-903 Copyright © American Heart Association, Inc. All rights reserved.